KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medpace Holdings (MEDP) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Medpace Holdings (MEDP) over the last 11 years, with Q4 2025 value amounting to $192.7 million.

  • Medpace Holdings' Cash from Operations rose 104.16% to $192.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $713.2 million, marking a year-over-year increase of 1714.94%. This contributed to the annual value of $713.2 million for FY2025, which is 1714.94% up from last year.
  • According to the latest figures from Q4 2025, Medpace Holdings' Cash from Operations is $192.7 million, which was up 104.16% from $246.2 million recorded in Q3 2025.
  • In the past 5 years, Medpace Holdings' Cash from Operations registered a high of $246.2 million during Q3 2025, and its lowest value of $46.3 million during Q1 2022.
  • In the last 5 years, Medpace Holdings' Cash from Operations had a median value of $115.4 million in 2023 and averaged $120.3 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first crashed by 3280.06% in 2021, then surged by 9280.05% in 2022.
  • Quarter analysis of 5 years shows Medpace Holdings' Cash from Operations stood at $70.9 million in 2021, then skyrocketed by 92.8% to $136.7 million in 2022, then grew by 14.42% to $156.4 million in 2023, then rose by 21.91% to $190.7 million in 2024, then grew by 1.04% to $192.7 million in 2025.
  • Its Cash from Operations was $192.7 million in Q4 2025, compared to $246.2 million in Q3 2025 and $148.5 million in Q2 2025.